Opinion|Videos|December 23, 2024
Using Technology for Early Detection of LEMS
A panelist discusses how enhanced screening protocols combined with predictive analytics can accelerate Lambert-Eaton myasthenic syndrome (LEMS) detection in high-risk populations like patients with small cell lung cancer (SCLC) while also exploring the potential of telemedicine to improve early diagnosis in underserved communities.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- How can improved screening protocols and the integration of predictive analytics in clinical practice enhance early detection of LEMS in high-risk patients, such as those with SCLC, and which patient populations should be prioritized?
- In what ways can telemedicine and digital health tools support earlier detection of LEMS, especially in underserved areas?
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Moderna’s mRNA Flu Vaccine After Phase 3 Success
2
Almost No Public Awareness of Lp(a), Elevated CVD Risk in the US: Katherine Wilemon
3
5 Novel FDA Approvals That Signal a Shift Toward Convenience-Driven Care
4
GLP-1 Plus Glucagon: The Mechanistic Case for Dual Receptor Agonism in Obesity and MASH
5